Abstract：Objective: To observe the clinical value of serum procalcitonin (PCT) and high-sensitivity C-reactive protein (hs-CRP) combined with clinical pulmonary infection score (CPIS) in prognosis evaluation of elderly patients with severe pneumonia (SP). Methods: This study included 92 elderly patients with severe pneumonia (severe group) and 30 elderly patients with ordinary pneumonia (ordinary group) who were admitted to the hospital from April 2020 to March 2022, and 30 elderly patients without major diseases (control group). Serum PCT and hs-CRP levels, and CPIS were compared among the groups. According to the survival status within 1 month after admission, patients in the severe group were divided into a survival group and a death group. Serum PCT and hs-CRP levels, and CPIS in patients with different prognoses were observed. The receiver operating characteristic (ROC) curve was used to analyze the prognostic value of serum PCT, and hs-CRP combined with CPIS in elderly patients with SP. Results: Serum PCT and hs-CRP levels, and CPIS in the severe group at admission were significantly higher than those in the ordinary group and the control group (P<0.05). Serum PCT and hs-CRP levels, and CPIS in the death group were significantly higher than those in the survival group (P<0.05). ROC curve analysis showed that the best cut-off values of serum PCT, hs-CRP, and CPIS were 9.595ng/mL, 17.615mg/L, and 8.175. All three could be used for the prognosis of elderly patients with SP (P<0.05). The sensitivity of the combination of the three in the prognosis of elderly patients with SP was higher than that of each index (P<0.05). Conclusion: Compared with patients with ordinary pneumonia and healthy elderly people, elderly patients with SP have higher serum PCT and hs-CRP levels, and higher CPIS. Combined detection of the three is of high value in the prognosis of elderly patients with SP. Therefore, close monitoring of the three indicators is recommended in clinical practice.
王一律, 王真, 钟文, 张晓娟, 陈睿. PCT和hs-CRP联合临床肺部感染评分对老年重症肺炎患者预后评估的价值[J]. 河北医学, 2023, 29(2): 289-293.
WANG Yilv, WANG Zhen, ZHONG Wen, et al. Value of PCT and hs-CRP Combined with Clinical Pulmonary Infection Score in Prognosis Evaluation of Elderly Patients with Severe Pneumonia. HeBei Med, 2023, 29(2): 289-293.
[1] 邹凡,刘明,崔栋慧,等.血管紧张素Ⅱ在重症肺炎肺损伤中的作用及损伤机制研究[J].成都医学院学报,2021,16(4):486-489. [2] 杨惠邻,钱红,沈锋,等.小剂量低分子肝素可改善老年重症肺炎患者预后:一项1173例患者的Meta分析[J].中华危重病急救医学,2020,32(1):26-32. [3] 曾余丰,葛金林,蒋龙翔.脑钠肽联合临床肺部感染评分对老年重症肺炎患者早期病情评估的价值[J].浙江医学,2020,42(20):2205-2208. [4] 刘跃辉,郝东宁,马肃,等.热毒宁注射液联合利奈唑胺治疗呼吸机相关性肺炎疗效及对血清PCT、IL-6和CRP水平的影响[J].中华中医药学刊,2020,38(12):209-212. [5] Mandell LA,Wunderink RG,Anzueto A,et al.Infectious diseases society of America/American thoracic society consensus guidelines on the management of community acquired pneumonia in adults[J].Clin Infect Dis,2007,44(Supplement 2):27-72. [6] 王菲,李松.乌司他丁对老年重症肺炎病人呼吸功能、肺表面活性蛋白及氧化应激的影响[J].实用老年医学,2020,34(1):54-57. [7] 张康,张亚青,谢凯,等.血必净注射液辅助治疗老年重症肺炎随机对照研究的Meta分析[J].中药新药与临床药理,2020,31(4):483-489. [8] 季金芳,孟海艳,施金梅,等.血清CRP、PCT和乳酸对老年肺部感染患者预后的临床价值[J].中华医院感染学杂志,2020,30(17):2628-2631.
2023, Vol. 29 
冀公网安备13080202000677号